Company’s Revolutionary Plant-Made Vaccine Technology Honored by International Panel

Indianapolis, IN - October 13, 2006

Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today that it has been recognized internationally for its contributions to the animal health industry. The company’s Animal Health business was honored as one of three finalists in the first annual Animal Pharm Industry Excellence Awards in the category of Best Technical Innovation. The Dow AgroSciences technology earning the honor was the company’s revolutionary Concert™ Plant-Cell-Produced vaccine production system.

“We are honored to be a finalist for this important industry award, not only because of the high caliber of companies represented through this program, but also because it highlights the dedication and talent of our employees,” said Butch Mercer, global business leader for Animal Health.

The Concert™ Plant-Cell-Produced System utilizes plant cells instead of whole plants in a secure, bio-contained environment to produce vaccines in a way that is safer, faster and more environmentally sound than traditional methods. The system uses only the necessary parts of the disease causing agent to stimulate immunity in a manufacturing process that is totally free of animal components.

In January of 2006, Dow AgroSciences received the world’s first ever regulatory approval for a plant-made vaccine from the USDA Center for Veterinary Biologics (CVB). This approval represented the first time any plant-made product had successfully demonstrated technology that met the stringent product development regulatory requirements, and was the first licensed vaccine produced using the Concert plant-cell-produced system.

“We are very proud of the accomplishments of our Animal Health team,” said Pete Siggelko, vice president, Plant Genetics & Biotechnology at Dow AgroSciences.  “Being the first company to ever register a plant-made vaccine was a remarkable accomplishment, and we are delighted that the excellence demonstrated by our team is being recognized on an international stage.”

Dow AgroSciences Animal Health leaders were in attendance at the awards ceremony, which took place today in London, England. 

About Dow AgroSciences LLC

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top tier agricultural company providing innovative crop protection, seeds, and biotechnology solutions to serve the world's growing population. A wholly owned subsidiary of The Dow Chemical Company, global sales for Dow AgroSciences are $3.4 billion. Learn more at www.concertvaccines.com.

About Animal Pharm

Animal Pharm News, published by Informa Healthcare, is the only global business news service for and about the animal health industry, with a total readership of 8,000 among animal health companies, regulatory agencies, government departments, professional and industry associations, consultancies and financial institutions. The brand also encompasses market and business reports focused on the industry, a directory of suppliers and animal health companies and a series of conferences. A portfolio of books and an industry-focused recruitment website are also in preparation.

™Trademark of Dow AgroSciences LLC

For Editorial Information:

Robyn Heine
Dow AgroSciences LLC
317.337.4807